[6-K] Apollomics Inc. Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Apollomics Inc. (APLM) reported that it has entered into a settlement agreement to fully resolve legal proceedings in the Grand Court of the Cayman Islands brought by two minority investors. The dispute arose from claims filed on July 22, 2024, related to the requested redemption of certain preferred shares before Apollomics completed its 2023 public merger with Maxpro Capital Acquisition Corporation. A stay order had previously been issued on September 12, 2025, and the parties are now in the process of submitting the settlement for court approval to conclude the litigation. The information about this settlement is also being incorporated by reference into Apollomics’ registration statements on Form S-8 and Form F-3.

Insights

Litigation and capital markets analyst

Apollomics moves to resolve Cayman preferred-share dispute via court-approved settlement.

Apollomics Inc. has reached a settlement agreement intended to fully resolve Cayman Islands litigation brought by two minority investors over the redemption of certain preferred shares tied to its 2023 merger with Maxpro Capital Acquisition Corporation. This follows a stay order issued on September 12, 2025, suggesting the parties had already paused active litigation while working toward resolution.

The settlement remains subject to approval by the Grand Court of the Cayman Islands, so the legal overhang is not formally concluded until the court accepts the agreement. Financial terms are not described in the provided content, so the direct economic impact cannot be assessed here, but eliminating litigation risk around pre-merger preferred share redemptions can be important for clarity in the capital structure.

The company states that information relating to the settlement is incorporated by reference into existing registration statements on Form S-8 and Form F-3, including File Nos. 333-272559, 333-278430, 333-278431 and 333-279549. This ensures that potential users of those registration statements have updated disclosure about the status of the Cayman litigation.

OMB APPROVAL
OMB Number:				3235-0116
Expires:		December 31, 2026
Estimated average burden
hours per response				8.7

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November, 2025.

Commission File Number 001-41670

Apollomics Inc.

Not Applicable

(Translation of registrant’s name into English)

989 E. Hillsdale Blvd., Suite 220, Foster City, California 94404

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

☒ Form 20-F   ☐ Form 40-F

Cayman Litigation Settlement

On November 19, 2025, Apollomics Inc. (the “Company”) announced that it entered into a settlement agreement (the “Settlement Agreement”) to fully resolve and conclude all matters (the “Settlement”) related to legal proceedings previously filed in the Grand Court of the Cayman Islands by two minority investors in the Company (the “Cayman Litigation”). As described in more detail in the Company’s Annual Report on Form 20-F for the year ended December 31, 2024, the Cayman Litigation involved claims issued on July 22, 2024 in the Grand Court of the Cayman Islands by an investment manager on behalf of two minority investors in the Company who had requested the redemption of certain preferred shares of the Company shortly before the Company’s 2023 consummation of the public merger with Maxpro Capital Acquisition Corporation. Please refer to the Company’s press release dated November 19, 2025, furnished as Exhibit 99.1 to this Form 6-K, for more details.

A stay order had previously been issued on September 12, 2025, as disclosed in a previous Form 6-K filed on September 25, 2025. The Company and the aforementioned minority investors are in the process of submitting the Settlement and Settlement Agreement for the court’s approval to conclude the associated litigation proceedings.

The information contained in this Form 6-K relating to the Settlement is incorporated by reference into the Company’s registration statements under the Securities Act, including its registration statements on Form S-8 (File No. 333-272559) and Form F-3 (File Nos. 333-278430, 333-278431 and 333-279549), and shall be a part thereof, to the extent not superseded by documents or reports subsequently filed or furnished.

Exhibit No.		Description
99.1		Press Release — Apollomics Announces Settlement of Cayman Litigation

2 of 3

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

APOLLOMICS INC.

(Registrant)

Date November 19, 2025

(Signature)^*

/s/ Peter Lin

Peter Lin, Chief Financial Officer

SEC 1815 (07-22) Potential persons who are to respond to the collection of information contained in this Form are not required to respond unless the Form displays a currently valid OMB control number.

3 of 3

FAQ

What did Apollomics Inc. (APLM) announce in this Form 6-K?

Apollomics Inc. announced that it entered into a settlement agreement intended to fully resolve legal proceedings in the Grand Court of the Cayman Islands brought by two minority investors over certain preferred share redemptions.

What was the Cayman litigation involving Apollomics (APLM) about?

The Cayman litigation involved claims issued on July 22, 2024 by an investment manager on behalf of two minority investors who had requested redemption of certain preferred shares shortly before Apollomics’ 2023 public merger with Maxpro Capital Acquisition Corporation.

Is the Apollomics Cayman settlement already final?

The settlement is not yet final; Apollomics and the minority investors are in the process of submitting the settlement and settlement agreement to the Grand Court of the Cayman Islands for approval to conclude the litigation proceedings.

What prior court action occurred in the Apollomics Cayman case?

A stay order was issued on September 12, 2025 in the Cayman proceedings, as previously disclosed by Apollomics in a Form 6-K filed on September 25, 2025.

How does this settlement affect Apollomics’ registration statements?

Information relating to the settlement is incorporated by reference into Apollomics’ registration statements under the Securities Act, including its Form S-8 (File No. 333-272559) and Form F-3 registration statements (File Nos. 333-278430, 333-278431 and 333-279549).

Where can investors find more details on the Apollomics settlement?

Additional details are provided in Apollomics’ press release dated November 19, 2025, which is furnished as Exhibit 99.1 to this Form 6-K.